Astrana Health, Inc.
US ˙ NasdaqCM ˙ US03763A2078

SecurityASTH / Astrana Health, Inc.
InsiderJohn Chiang
This page shows the track record and history of Chiang John insider trades in Astrana Health, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by John Chiang in ASTH / Astrana Health, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2019-06-14 100 16.3100 100 16.3100 1,631 98 21.41 510 31.27

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ASTH / Astrana Health, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by John Chiang in ASTH / Astrana Health, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ASTH / Astrana Health, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-08-14 2025-08-13 4 Chiang John ASTH Common Stock F - Taxes D 29.6300 -12,284 -364 30,848
2025-08-14 2025-08-13 4 Chiang John ASTH Common Stock M - Exercise D 18.2000 20,000 364 43,132
2025-06-13 2025-06-11 4 Chiang John ASTH Common Stock A - Award D 6,449 23,132
2024-11-20 2024-11-19 4 Chiang John ASTH Common Stock F - Taxes D 40.9300 -681 -28 16,683
2024-11-20 2024-11-19 4 Chiang John ASTH Common Stock M - Exercise D 18.4100 1,515 28 17,364
2024-09-11 2024-09-09 4 Chiang John ASTH Common Stock F - Taxes D 47.3500 -3,565 -169 15,849
2024-09-11 2024-09-09 4 Chiang John ASTH Common Stock M - Exercise D 15.3500 11,000 169 19,414
2024-08-14 2024-08-13 4 Chiang John ASTH Common Stock A - Award D 3,564 8,414
2023-12-18 2023-12-15 4 Chiang John AMEH Common Stock A - Award D 4,750 4,850
2022-01-24 2022-01-20 4 Chiang John AMEH Stock Option (right to buy) A - Award D 53.01 8,500 8,500
2020-11-13 2020-11-11 4 Chiang John AMEH Stock Option (right to buy) A - Award D 18.20 20,000 20,000
2020-04-14 2020-02-05 4/A Chiang John AMEH Stock Option (right to buy) A - Award D 18.41 1,515 12,515
2020-02-21 2020-02-05 4 Chiang John AMEH Stock Option (right to buy) A - Award D 17.57 1,578 12,578
2020-02-21 2020-02-05 4/A Chiang John AMEH Stock Option (right to buy) J - Other D 17.57 -900 11,000
2019-12-26 2019-11-25 4 Chiang John AMEH Stock Options A - Award D 17.57 900 11,900
2019-11-20 2019-10-11 4 Chiang John AMEH Stock Options A - Award D 15.35 11,000 11,000
2019-06-18 2019-06-14 4 Chiang John AMEH Common Stock P - Purchase D 16.3100 100 2 100
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)